Physician profile
Michael Ernest Fusaro
NPI 1154407500
$1,220.09
in general payments reported to CMS, 2019-2025
9 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $28.12 · 2021: $216 · 2022: $147 · 2023: $72.21 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $530.60 | 2021-2025 | Apligraf, Puraply |
| Smith+Nephew, INC. | $336.95 | 2019-2025 | Collagenase Santyl |
| Reprise Biomedical, INC. | $163.05 | 2025 | Miro3d |
| Tactile Systems Technology INC | $55.68 | 2025 | Flexitouch Plus, Nimbl |
| Integra Lifesciences Corporation | $40.84 | 2019 | |
| Next Science LLC | $30.60 | 2023 | Surgx, Blastx, Xperience |
| Kci USA, INC. | $28.69 | 2021 | |
| Urgo Medical North America, LLC | $22.26 | 2025 | Urgok2 |
| Terumo Medical Corporation | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fusaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.